Altered radiation responses of breast cancer cells resistant to hormonal therapy

Endocrine therapy agents (the selective estrogen receptor (ER) modulators such as tamoxifen or the selective ER down-regulators such as ICI 182,780) are key treatment regimens for hormone receptor-positive breast cancers. While these drugs are very effective in controlling ER-positive breast cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales: Luzhna, Lidiya, Lykkesfeldt, Anne E., Kovalchuk, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359324/
https://www.ncbi.nlm.nih.gov/pubmed/25682200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359324/
https://www.ncbi.nlm.nih.gov/pubmed/25682200

Ejemplares similares